- STAT+: Combination of pancreatic cancer drugs from Tango, Revolution leads to high response rateA combination of pancreatic cancer drugs from Tango Therapeutics and Revolution Medicines led to a strong response rate in an early-stage trial.STAT · 1mo ago↗ source
- Innovation alone is no longer enough in biopharma<p>In biopharma, the next edge may come from the systems that turn discovery into scale.</p>BioPharma Dive · 1mo ago↗ source
- Precision under pressure: Logistic solutions for nuclear medicine scalability<p>Racing the clock: How precision logistics deliver life-saving nuclear medicine.</p>BioPharma Dive · 1mo ago↗ source